Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
95% Trichloroacetic Acid for CIN 1 or Less
NCT06188104Phase 3Withdrawn
- Sponsor
- Ministry of Public Health
- Start
- Nov 2023
- Primary completion
- Dec 2023
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trichloroacetic acid in cervical intraepithelial neoplasia (CIN), sponsored by Ministry of Public Health. Planned start Nov 2023; status: withdrawn.
02
Drugs
trichloroacetic acid
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT06188104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06188104.